Crucial
Differences in the Mechanism of Action of Cell Transplantation and
(Chemical) Drug Therapy

Cell transplantation is a vastly different
approach to medical therapy and cannot be immediately understood by
mind accustomed to deal with (chemical) drug therapy.

In order to comprehend this statement, you should
visualize that

everything in the living body is in constant
motion: electrons, protons, and other elementary particles of each
atom, all atoms, all molecules, all cell organelles of every cell, as
well as all fluids, which represent between 75 and 55% of body weight
(depending upon age),

and that

there is electromagnetic radiation
associated with all such movement, a subject almost completely
neglected by medical science,

and finally the following.

Every cell in your body is programmed to die,
and it does so before you die. (The sole exception may be certain
neurons.)

All cells of our body are being continuously
replaced, albeit each kind with different speed.

In every disease the principal cells of a
diseased organ(s) die faster than the sick body is able to replace them.

When the quantity of principal cells of a diseased
organ(s) drops below certain limit, such organ(s) dies.

If it is a vitally important organ, without which
one cannot live, such as heart, or brain, for example, and surgeons cannot
replace such a dying organ(s), the sick organism will die, too.

Current medicine knows of one treatment only when
it becomes mandatory to replace dead cells, tissues, or organs:
transplantation.

Transplantation of organs from human
donors, such as heart, kidney, liver, etc., have become fairly common
nowadays. These are life saving major surgical procedures, usually carried
out as
a 'treatment of last resort'.

Besides the surgical risk, there is always a
problem of rejection: the body of the recipient patient rejects
transplanted organ from another body with guarantee, and the only way to
prevent it is by taking immunosuppressants for the rest of patients life.
These drugs can stop a rejection for some time, but only at the expense of
serious, often life-endangering, complications.

Some organs cannot be transplanted, such as
brain, immune system, so that many diseases cannot be treated by organ
transplantation.

BCRO fetal precursor cell transplantation has historically
preceded organ transplantation by several decades. It will
dominate the medicine of 21st century. The main reasons for
such statements are:

BCRO fetal precursor cell transplantation is a minor
procedure for a patient, and for that reason it can be, and should
be, used in the earlier stages of those diseases that current
medicine cannot cure, or even treat. It means that there is no
logical reason to wait until the end-stage, as is the case with organ
transplantation.

One of the reasons why BCRO cell
transplantation is such a simple procedure for a patient to go through
is the principle of 'homing'.
'Homing' means that the respective cells do not have to be
implanted into a damaged organ, (i.e. liver cells into liver), they
can be implanted into more accessible superficial tissues, (e.g. under
the aponeurosis of an abdominal muscle), because they will find
their way into the damaged organ, as if 'attracted' by it, and
will do so within 7 days of the date of implantation.

Every diseased organ can be treated by BCRO
cell transplantation.

The transplanted cells can bring back to
life (or repair) those cells of diseased organ which actually have not died,
just stopped functioning as a result of the disease.
In other words, besides transplanting new cells there is usually another
mechanism of action of cell transplantation: a 'direct
stimulation of regeneration (or repair)'.

If cells are properly prepared, such as by
BCRO method, they can be implanted without immunosuppression, and
thus avoid all complications caused by the use of such medications.

The therapeutic effect of drugs of chemical origin
is not as broad as those of any of the 200+ known types of cells
transplantated into a body with insufficient quantity or quality of a
particular cell type(s).

Drugs of chemical origin are used to modify a
specific function, and their effect is usually narrowly focused.

You should be awarethat there are two
schools of medical thought in the field of BCRO type cell transplantation
today:

1.

Recent U.S. school, whereby a
transplantation of only one type of cell is used for the
treatment of patient's disease, i.e. pancreatic islet cells to treat
diabetes mellitus and diabetic complications, such as
retinopathy, nephropathy, neuropathy, diabetic vascular disease,
etc.

2.

Original German school, whereby
a patient receives a simultaneous transplantation of several
types of cells for the treatment of his/her disease(s);
the choice of transplanted cells depends upon the pathophysiology of
the patient's disease(s).

As an example, a patient with type 1
(insulin-dependent) diabetes mellitus with complications, will
usually receive - besides pancreatic islet cells -

at least five other types of cells of all
those organs or tissues, that no longer function properly as a
result of many years' lasting metabolic abnormality caused by
diabetes mellitus.

In other words, the German school believes
that by the time a patient undergoes cell transplantation,
her/his diabetes mellitus had become very advanced,

and there is an impairment of some other
organs, besides Langerhans islets of pancreas, which all
require treatment by cell transplantation.

According to the German school, cell
transplant's combination(s) used for the treatment of complications of
type 1 diabetes mellitus is different from that used for a
patient with complications of type 2 diabetes mellitus.

A patient with complications of type 2 diabetes
mellitus can be successfully treated by cell transplantation also(!),
with the exception of significantly obese patients in whom the
treatment of obesity has been repeatedly unsuccessful.

The German school does agree with the U.S. school
in some clinical situations, such as for example in cases where the
patient is a small child that just became ill with type 1 diabetes mellitus: the
treatment by implanting of pancreatic islet cells only would be
perfectly adequate here.

BCRO clinical method of cell transplantation
based on the German school requires that the
treatment be 'individualized' by 'tailoring' the combination of
cell transplants to a specific disease of a specific patient.

Under the Oath of Hippocrates physicians should
treat their patients the best way they know how.

When the disease(s) of a specific patient requires
and responds to drugs of chemical origin, he should be treated that way,
when patient's disease(s) requires and responds to cell
transplantation, there should be no hesitation to use such a treatment,
and when a combination of both is necessary, so be it.

There are no incurable diseases only those that
we do not know how to cure yet. Given the opportunity the cell
transplantation will lower the number of incurable diseases.

BCRO fetal precursor cell
transplantation, has been used successfully for 80+
years as treatment of many diseases

for which modern medicine has had no therapy
(i.e. incurable), or

in which 'state-of-art' therapies stopped being
effective (i.e. no longer treatable),

in documented over 5 millions of patients worldwide.
Physicians can learn about it in a textbook by E. Michael Molnar, M.D.:
Fetal Precursor Cell
Transplantation, BCRO Fetal Precursor Cell Transplantation", published
in 2014 by www.amazon.com
On
the same web site the general readership can find out all about it in
the book by the same author: Treatment of Incurable and No Longer
Treatable Diseases, published in January 2015, as well as in his
autobiography: Diseases and Genocide are
not Our Destiny. You can buy it as 'free reader download for PC' as
well as Kindle Book.